MedTrace Logo

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

NCT00947843 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2016-10-13

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and tolerability between clopidogrel resinate and clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD equivalents.

Conditions

Interventions

DRUG

aspirin + pregrel (Clopidogrel resinate)

DRUG

aspirin + placebo

DRUG

aspirin + plavix (Clopidogrel bisulfate)

Sponsors & Collaborators

  • CKD Pharmaceutical Limited

    collaborator UNKNOWN

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Ki-Bae Seung, MD, PhD · Seoul St. Mary's Hospital

  • Chung-Hwan Gwak, MD, PhD · Gyeongsang National University Hospital

  • Kwon-Sam Kim, MD,PhD · Kyung Hee University Hospital

  • Soon-Jun Hong, MD,PhD · Korea University Anam Hospital

  • Tae-Ho Park, MD,PhD · Dong-A medical center

  • Sang-Hyun Kim, MD,PhD · Seoul Metropolitan Boramae Hospital

  • Seung-Jea Tahk, MD,PhD · Ajou University Medical Center

  • Seung-Jae Joo, MD,PhD · Jeju National University Hospital

  • Young-Jin Choi, MD,PhD · Hallym University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-10-31
Completion
2016-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00947843 on ClinicalTrials.gov